Skip to main content

Tarr Mark J's Form 4 filing

Encompass Health Corp (EHC) · filed May 1, 2024

Accession no.
0001127602-24-013718
Filed
May 1, 2024
Trade date
Apr 30, 2024
Filing delay
1 day
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $3.75M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Tarr Mark JCIK 0001304057Director, Officer (President & CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Apr 30, 2024Encompass Health Common StockMOption exerciseAcquired+19,460$35.83+$697,251.8573,558Direct
Apr 30, 2024Encompass Health Common StockMOption exerciseAcquired+25,516$29.06+$741,494.96599,074Direct
Apr 30, 2024Encompass Health Common StockSSaleDisposed−44,976$83.27−$3,745,151.52554,098Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Apr 30, 2024Encompass Health Common StockMOption exerciseDisposed−19,460$0.00$00Direct
Apr 30, 2024Encompass Health Common StockMOption exerciseDisposed−25,516$0.00$00Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)